Beijing Wantai Biological Pharmacy Enterprise
603392.SS
#2201
Rank
ยฃ6.26 B
Marketcap
ยฃ4.95
Share price
0.37%
Change (1 day)
-39.62%
Change (1 year)

Revenue for Beijing Wantai Biological Pharmacy Enterprise (603392.SS)

Revenue in 2025 (TTM): ยฃ0.18 Billion

According to Beijing Wantai Biological Pharmacy Enterprise's latest financial reports the company's current revenue (TTM ) is ยฃ0.18 Billion. In 2024 the company made a revenue of ยฃ0.24 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Beijing Wantai Biological Pharmacy Enterprise from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.18 B-26.79%
2024 ยฃ0.24 B-59.64%
2023 ยฃ0.61 B-55.11%
2022 ยฃ1.37 B107.51%
2021 ยฃ0.66 B160.54%
2020 ยฃ0.25 B95.3%
2019 ยฃ0.13 B